Dialysis News and Research

Latest Dialysis News and Research

Doping agent Epo could be effective against Covid-19

Doping agent Epo could be effective against Covid-19

Researchers identify immune cell that predicts transplant patient's risk of organ rejection

Researchers identify immune cell that predicts transplant patient's risk of organ rejection

‘I couldn’t let her be alone’: A peaceful death amid the COVID scourge

‘I couldn’t let her be alone’: A peaceful death amid the COVID scourge

New COVID-19 Kidney / Transplant Listening & Resource Center launched

New COVID-19 Kidney / Transplant Listening & Resource Center launched

Study finds significant variation in trust of health information by Hispanics

Study finds significant variation in trust of health information by Hispanics

Chronic kidney disease medication doesn’t work, shows study

Chronic kidney disease medication doesn’t work, shows study

Study shows generic drug does not slow kidney disease

Study shows generic drug does not slow kidney disease

Promising treatment does not guard against complication in type 1 diabetes

Promising treatment does not guard against complication in type 1 diabetes

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

Scottish biotech Invizius seeks Series A funding for breakthrough in dialysis treatment

Scottish biotech Invizius seeks Series A funding for breakthrough in dialysis treatment

Kidney failure due to AKI linked to significant morbidity and mortality

Kidney failure due to AKI linked to significant morbidity and mortality

Cell signaling pathway could treat chronic kidney disease and other medical conditions

Cell signaling pathway could treat chronic kidney disease and other medical conditions

NIH launches a centralized, secure enclave to store and study COVID-19 patient data

NIH launches a centralized, secure enclave to store and study COVID-19 patient data

At a time of great need, public health lacks ‘lobbying muscle’

At a time of great need, public health lacks ‘lobbying muscle’

A family with five doctors — and two COVID deaths

A family with five doctors — and two COVID deaths

Cys-C protein can predict risk of cardiovascular and renal diseases

Cys-C protein can predict risk of cardiovascular and renal diseases

Identifying key predictors of mortality in young dialysis patients

Identifying key predictors of mortality in young dialysis patients

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Indirect viral infection of the kidneys by SARS-CoV-2-induced inflammatory reaction

Indirect viral infection of the kidneys by SARS-CoV-2-induced inflammatory reaction

SARS-CoV-2 infection causes specific kidney proximal tubular injury

SARS-CoV-2 infection causes specific kidney proximal tubular injury

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.